Photo of Professor Frank Tanser

Professor Frank Tanser

Research Director of the Epidemiology and Population Studies Group: Africa Centre for Population Health

Professor of Epidemiology in the Faculty of Health Sciences: University of KwaZulu Natal

Honorary Professor: Institute of Epidemiology and Health Care, University College London

Prof Frank Tanser
P.O. Box 198
Mtubatuba 3935
South Africa

E: This email address is being protected from spambots. You need JavaScript enabled to view it.
T: +27 (0)35 5507509

NICHD Tanser F & Bärnighausen T,                                                                                    01/01/16 – 12/31/20

Causal Pathways to population health impact of HIV antiretroviral treatment (R01) 

Goal: to identify optimal strategies to deliver ART in poor rural communities in SSA, to ensure wide and equitable access to ART and maximal preventive effects of ART

Role: Principal Investigator

 

097410/Z/11/Z (Wellcome Trust)         Pillay, Tanser, Bärnighausen, Herbst                       10/01/12 –09/30/15

Africa Centre for Health and Population Studies

Goal: Research focusing on community-based health and population research of   importance to developing     countries, focusing on intervention and implementation of health policies

Role: Co-Investigator

 

DHF20327/1 (Discovery Fund)                Tanser & Herbst                                 01/01/12 – 12/31/14   

Elimination of urinary scistosomiasis infection in children

Goal:  Eliminate urinary schistosomiasis infection in school children in primary and secondary schools in a severely affected area in KwaZulu-Natal.

Role: Principal Investigator

Medical Research Council SA (MRC Flagship) Tanser & de Oliveira           04/01/2014- 03/31/2017

A multi-disciplinary approach to understand the cause and consequences of HIV transmission and drug resistance in a hyper-epidemic setting in rural South Africa.

Goal: Quantify HIV transmission and drug resistance patterns and to identify the most effective combination of HIV prevention and treatment approaches in a hyperendemic rural South African setting.

Role: Principal Investigator

 

2011-375 (ANRS)                   Pillay, Newell & Dabis                                                          04/01/14 –03/01/17 and

2011-375 (International Initiative for Impact Evaluation)                                                                          

Antiretroviral Treatment as Prevention (TasP).  A cluster-randomised trial in Hlabisa sub-District, KZN, SA- Phase II

Goal: HIV testing of all members of a community, followed by immediate ART initiation of all, or nearly all, HIV-infected individuals regardless of immunological or clinical staging will prevent onward transmission and reduce HIV incidence in this population.

Role: Co-Investigator

             

R01HD074267-02 (NIH)                          Bland & Rochat                                     08/01/12 – 05/31/15                       

 Maternal HIV disclosure to school-aged children: a randomized controlled trial of a family-based intervention.

Goal: The goal is to test the efficacy of an intervention which aims to increase rates of maternal HIV disclosure to HIV-uninfected children aged 6-9 years; improve health promotion and custody planning for mothers and their children.

Role: Co-Investigator

 

5U01A1069924-5 (NIH through University of Bern)   Egger, Boulle, Tanser          06/01/11 – 05/01/16                                       

International epidemiological databases to evaluate AIDS (IeDEA)

Goal: Conduct clinical, epidemiological and health services research in order to inform HIV/AIDS and TB service delivery in southern Africa, to increase the capacity for delivering Highly Active Antiretroviral Treatment (HAART) and, ultimately, to improve the prognosis of people living with HIV and AIDS in southern Africa.

Role: Local Principal Investigator

2016 

  1. Hontelez, J. A. C., Tanser, F. C., Naidu, K. K., Pillay, D., & Bärnighausen, T. (2016). The Effect of Antiretroviral Treatment on Health Care Utilization in Rural South Africa: A Population-Based Cohort Study. PloS One 11(7), e0158015. http://doi.org/10.1371/journal.pone.0158015

  2. Manasa, J., Danaviah, S., Lessells, R. J., Elshareef, M., Tanser, F., Wilkinson, E., … de Oliveira, T. (2016). Increasing HIV-1 drug resistance between 2010 and 2012 in adults participating in population-based HIV surveillance in rural KwaZulu-Natal South Africa. AIDS Research and Human Retroviruses. http://doi.org/10.1089/AID.2015.0225

  3. Oldenburg, C. E., Bärnighausen, T., Tanser, F., Iwuji, C. C., De Gruttola, V., Seage, G. R., … Harling, G. (2016). Antiretroviral therapy to prevent HIV acquisition in serodiscordant couples in a hyperendemic community in rural South Africa. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. http://doi.org/10.1093/cid/ciw335

  4. Yates, T. A., Tanser, F., & Abubakar, I. (2016). Plan Beta for tuberculosis: it’s time to think seriously about poorly ventilated congregate settings. The International Journal of Tuberculosis and Lung Disease 20(1), 5–10. http://doi.org/10.5588/ijtld.15.0494

2015 

  1. Anekwe, T. D., Newell, M.-L., Tanser, F., Pillay, D., & Bärnighausen, T. (2015). The effect of childhood measles vaccination on educational attainment: A mother-fixed-effects study in rural South Africa. Vaccine. http://doi.org/10.1016/j.vaccine.2015.04.072
  2. Bor, J., Rosen, S., Chimbindi, N., Haber, N., Herbst, K., Mutevedzi, T., … Bärnighausen, T. (2015). Mass HIV Treatment and Sex Disparities in Life Expectancy: Demographic Surveillance in Rural South Africa. PLoS Medicine, 12(11). http://doi.org/10.1371/journal.pmed.1001905
  3. Chimbindi, N., Bor, J., Newell, M.-L., Tanser, F., Baltusen, R., Hontelez, J., … Bärnighausen, T. (2015). Time and money: the true costs of health care utilization for patients receiving “free” HIV/TB care and treatment in rural KwaZulu-Natal. JAIDS Journal of Acquired Immune Deficiency Syndromes, 1. http://doi.org/10.1097/QAI.0000000000000728
  4. Cornell, M., Johnson, L. F., Schomaker, M., Tanser, F., Maskew, M., Wood, R., … Egger, M. (2015). Age and mortality in ART programs in South Africa.
  5. Cornell, M., Johnson, L. F., Schomaker, M., Tanser, F., Maskew, M., Wood, R., … for the International Epidemiologic Databases to Evaluate AIDS-Southern Africa Collaboration.(2015). Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study. The Lancet HIV. Retrieved from http://www.sciencedirect.com/science/article/pii/S2352301815001137
  6. Grimsrud, A., Cornell, M., Schomaker, M., Fox, M. P., Orrell, C., Prozesky, H., … Myer, L. (2015). CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study. Journal of Epidemiology and Community Health, jech–2015–206629. http://doi.org/10.1136/jech-2015-206629
  7. Harling, G., Newell, M., Tanser, F., & Bärnighausen, T. W. (2015). Partner-age disparity and HIV incidence risk for older women in rural South Africa. AIDS and Behavior. http://doi.org/10.1007/s10461-014-0952-3
  8. Harling, G., Tanser, F., Mutevedzi, T., & Bärnighausen, T. (2015a). Assessing the validity of respondents’ reports of their partners’ ages in a rural South African population-based cohort. BMJ Open, 5(3), e005638. http://doi.org/10.1136/bmjopen-2014-005638
  9. Herbst, K., Law, M., Geldsetzer, P., Tanser, F., Harling, G., & Bärnighausen, T. (2015). Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies. Current Opinion in HIV and AIDS. Retrieved from http://europepmc.org/abstract/med/26371462
  10. Johnson, L. F., Dorrington, R. E., Laubscher, R., Hoffmann, C. J., Wood, R., Fox, M. P., … Boulle, A. (2015). A comparison of death recording by health centres and civil registration in South Africans receiving antiretroviral treatment. Journal of the International AIDS Society, 18(1). http://doi.org/10.7448/IAS.18.1.20628
  11. Otieno, G., Marinda, E., Bärnighausen, T., & Tanser, F. (2015). High rates of homicide in a rural South African population (2000–2008): findings from a population-based cohort study. Population Health Metrics, 13(1). http://doi.org/10.1186/s12963-015-0054-0
  12. Porter, M., Davies, M.-A., Mapani, M. K., Rabie, H., Phiri, S., Nuttall, J., … Eley, B. (2015). Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012. Journal of Acquired Immune Deficiency Syndromes (1999), 69(5), 593–601. http://doi.org/10.1097/QAI.0000000000000683
  13. Schomaker, M., Davies, M.-A., Malateste, K., Renner, L., Sawry, S., N’Gbeche, S., … Haby.. (2015). Growth and mortality outcomes for different ART criteria in children aged 1-5years: a causal modelling analysis from West and Southern Africa.
  14. Schomaker, M., Davies, M., Malateste, K., Renner, L., Sawry, S., N’Gbeche, S., … Leroy, V. (2015). Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children aged 1-5 Years: A Causal Modelling Analysis. Epidemiology (Cambridge, Mass.). Retrieved from http://europepmc.org/abstract/med/26479876
  15. Tanser, F., Bärnighausen, T., Vandormael, A., & Dobra, A. (2015). HIV treatment cascade in migrants and mobile populations  Current Opinion in HIV and AIDS, 1. http://doi.org/10.1097/COH.0000000000000192
  16. Vandormael, A., Boulware, D., Tanser, F., Bärnighuasen, T., Stott, K., & de Oliveira, T. (2015). Virologic monitoring can be a cost-effective strategy to diagnose treatment failure on first-line ART. Journal of Acquired Immune Deficiency Syndromes (1999). Retrieved from http://europepmc.org/abstract/med/26484740
  17. Yates, T. A., Abubakar, I., & Tanser, F. (2015). HIV Infection and the Transmission of Tuberculosis. The Journal of Infectious Diseases, 211(9), 1510. http://doi.org/10.1093/infdis/jiu628

 2014

  1. Feigl, A.B., Tanser, F., Bärnighausen, T.W., 2014. The effect of HIV and the modifying effect of antiretroviral therapy on body-mass index and blood pressure levels in rural South Africa. The Lancet Global Health, Consortium of Universities for Global Health, 5th annual conference 2, Supplement 1, S21. doi:10.1016/S2214-109X(15)70043-4
  2. Harling, G., Newell, M.-L., Tanser, F., Kawachi, I., Subramanian, S.V., Bärnighausen, T., 2014. Do Age-Disparate Relationships Drive HIV Incidence in Young Women? Evidence from a Population Cohort in Rural KwaZulu-Natal, South Africa. J. Acquir. Immune Defic. Syndr. 66, 443–451. doi:10.1097/QAI.0000000000000198
  3. Yates, T.A., Abubakar, I., Tanser, F., 2014. HIV Infection and the Transmission of Tuberculosis. J Infect Dis. doi:10.1093/infdis/jiu628
  4. Vandormael, A., Newell, M.-L., Bärnighausen, T., Tanser, F., 2014. Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004-12: a prospective cohort study. Lancet Glob Health 2, e209–e215. doi:10.1016/S2214-109X(14)70018-X
  5. Raifman, J., Chetty, T., Tanser, F., Mutevedzi, T., Matthews, P., Herbst, K., Pillay, D., Bärnighausen, T., 2014. Preventing Unintended Pregnancy and HIV Transmission: Effects of the HIV Treatment Cascade on Contraceptive Use and Choice in Rural KwaZulu-Natal. JAIDS Journal of Acquired Immune Deficiency Syndromes 67, S218–S227. doi:10.1097/QAI.0000000000000373
  6. Ross, E., Tanser, F., Pei, P., Newell, M.-L., Losina, E., Thiebaut, R., Weinstein, M., Freedberg, K., Anglaret, X., Scott, C., Dabis, F., Walensky, R., 2014. The Impact of the 2013 WHO Antiretroviral Therapy Guidelines on the Feasibility of HIV Population Prevention Trials. HIV Clinical Trials 15, 185–198. doi:10.1310/hct1505-185
  7. Tanser, F., de Oliveira, T., Maheu-Giroux, M., Bärnighausen, T., 2014. Concentrated HIV subepidemics in generalized epidemic settings. Curr Opin HIV AIDS 9, 115–125. doi:10.1097/COH.0000000000000034

 

2013

  1. Bärnighausen, T., Tanser, F., Herbst, K., Mutevedzi, T., Mossong, J., Newell, M.-L., 2013. Structural barriers to antiretroviral treatment: a study using population-based CD4 cell count and linked antiretroviral treatment programme data. The Lancet 382, S5. doi:10.1016/S0140-6736(13)62253-9
  2. McGrath, N., Eaton, J.W., Bärnighausen, T.W., Tanser, F., Newell, M.-L., 2013. Sexual behaviour in a rural high HIV prevalence South African community: time trends in the antiretroviral treatment era. AIDS 27, 2461–2470. doi:10.1097/01.aids.0000432473.69250.19
  3. Hontelez, J.A.C., Lurie, M.N., Bärnighausen, T., Bakker, R., Baltussen, R., Tanser, F., Hallett, T.B., Newell, M.-L., de Vlas, S.J., 2013. Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study. PLoS Med. 10. doi:10.1371/journal.pmed.1001534
  4. Iwuji, C.C., Orne-Gliemann, J., Tanser, F., Boyer, S., Lessells, R.J., Lert, F., Imrie, J., Bärnighausen, T., Rekacewicz, C., Bazin, B., Newell, M.L., Dabis, F., Okesola, N., Bland, R., de Oliveira, T., Viljoen, J., Newell, C., Naidu, K., Lert, F., Dray-Spira, R., Larmarange, J., Spire, B., Chaix, M.L., Karcher, S., Thiébaut, R., Freeberg, K., 2013. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (treatment as prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Trials 14, 1–15. doi:10.1186/1745-6215-14-230
  5. Mossong, J., Grapsa, E., Tanser, F., Bärnighausen, T., Newell, M.-L., 2013. Modelling HIV incidence and survival from age-specific seroprevalence after antiretroviral treatment scale-up in rural South Africa. AIDS 27, 2471–2479. doi:10.1097/01.aids.0000432475.14992.da
  6. Namosha, E., Sartorius, B., Tanser, F., 2013. Spatial clustering of all-cause and HIV-related mortality in a rural South African population (2000-2006). PLoS ONE 8. doi:10.1371/journal.pone.0069279
  7. Zaidi, J., Grapsa, E., Tanser, F., Newell, M.-L., Bärnighausen, T., 2013. Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment. AIDS 27, 2301–2305. doi:10.1097/QAD.0b013e328362e832
  8. Tanser, F., Jones, K.G., Viljoen, J., Imrie, J., Grapsa, E., Newell, M.-L., 2013. Human papillomavirus seropositivity and subsequent risk of HIV acquisition in rural South African women. Sex Transm Dis 40, 601–606. doi:10.1097/OLQ.0b013e3182918578
  9. Tanser, F., Bärnighausen, T., Grapsa, E., Zaidi, J., Newell, M.-L., 2013. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 339, 966–971. doi:10.1126/science.1228160

2012

  1. Barnighausen, T., Tanser, F., Malaza, A., Herbst, K., Newell, M.-L., 2012. HIV status and participation in HIV surveillance in the era of antiretroviral treatment: a study of linked population-based and clinical data in rural South Africa. Trop Med Int Health 17, e103–e110. doi:10.1111/j.1365-3156.2012.02928.x
  2. Bärnighausen, T., Tanser, F., Dabis, F., Newell, M.-L., 2012. Interventions to improve the performance of HIV health systems for treatment-as-prevention in sub-Saharan Africa: the experimental evidence. Curr Opin HIV AIDS 7, 140–150. doi:10.1097/COH.0b013e32834fc1df
  3. Bor, J., Tanser, F., Newell, M.-L., Bärnighausen, T., 2012a. Nearly full employment recovery among South African HIV patients on antiretroviral therapy: evidence from a large population cohort. Health Aff (Millwood) 31, 1459–1469. doi:10.1377/hlthaff.2012.0407
  4. Maheswaran, H., Thulare, H., Stanistreet, D., Tanser, F., Newell, M.-L., 2012. Starting a home and mobile HIV testing service in a rural area of South Africa. J. Acquir. Immune Defic. Syndr. 59, e43–46. doi:10.1097/QAI.0b013e3182414ed7
  5. Hontelez, J.A.C., de Vlas, S.J., Baltussen, R., Newell, M.-L., Bakker, R., Tanser, F., Lurie, M., Bärnighausen, T., 2012. The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa. AIDS 26 Suppl 1, S19–30. doi:10.1097/QAD.0b013e3283558526
  6. Zhou, J., Lurie, M.N., Bärnighausen, T., McGarvey, S.T., Newell, M.-L., Tanser, F., 2012. Determinants and spatial patterns of adult overweight and hypertension in a high HIV prevalence rural South African population. Health Place 18, 1300–1306. doi:10.1016/j.healthplace.2012.09.001

2011

  1. Chaiyachati, K., Hirschhorn, L.R., Tanser, F., Newell, M.-L., Bärnighausen, T., 2011. Validating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South Africa. AIDS Patient Care STDS 25, 163–170. doi:10.1089/apc.2010.0257
  2. Bor, J., Bärnighausen, T., Newell, C., Tanser, F., Newell, M.-L., 2011. Social exposure to an antiretroviral treatment programme in rural KwaZulu-Natal. Trop. Med. Int. Health 16, 988–994. doi:10.1111/j.1365-3156.2011.02795.x
  3. Hontelez, J.A.C., Lurie, M.N., Newell, M.-L., Bakker, R., Tanser, F., Bärnighausen, T., Baltussen, R., de Vlas, S.J., 2011. Ageing with HIV in South Africa. AIDS 25, 1665–1667. doi:10.1097/QAD.0b013e32834982ea
  4. Hontelez, J.A.C., Nagelkerke, N., Bärnighausen, T., Bakker, R., Tanser, F., Newell, M.-L., Lurie, M.N., Baltussen, R., de Vlas, S.J., 2011. The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model. Vaccine 29, 6100–6106. doi:10.1016/j.vaccine.2011.06.059
  5. Hontelez, J.A.C., de Vlas, S.J., Tanser, F., Bakker, R., Bärnighausen, T., Newell, M.-L., Baltussen, R., Lurie, M.N., 2011a. The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa. PLoS ONE 6. doi:10.1371/journal.pone.0021919
  6. Imrie, J., Tanser, F., 2011. Targeting strategies and behaviour change to combat the HIV epidemic in southern Africa. Future Virology 6, 793–800. doi:10.2217/fvl.11.54
  7. Tanser, F., Bärnighausen, T., Hund, L., Garnett, G.P., McGrath, N., Newell, M.-L., 2011. Role of concurrency in generalised HIV epidemics. The Lancet 378, 1845–1846. doi:10.1016/S0140-6736(11)61806-0
  8. Tanser, F., Bärnighausen, T., Hund, L., Garnett, G.P., McGrath, N., Newell, M.-L., 2011. Effect of concurrent sexual partnerships on rate of new HIV infections in a high-prevalence, rural South African population: a cohort study. Lancet 378, 247–255. doi:10.1016/S0140-6736(11)60779-4
  9. Ott, M.Q., Bärnighausen, T., Tanser, F., Lurie, M.N., Newell, M.-L., 2011. Age-gaps in sexual partnerships: seeing beyond “sugar daddies.” AIDS 25, 861–863. doi:10.1097/QAD.0b013e32834344c9

2010

  1. Bärnighausen, T., Tanser, F., Hallett, T., Newell, M.-L., 2010. Short communication: Prioritizing communities for HIV prevention in sub-Saharan Africa. AIDS Res. Hum. Retroviruses 26, 401–405. doi:10.1089/aid.2009.0236
  2. Cooke, G.S., Tanser, F.C., Bärnighausen, T.W., Newell, M.-L., 2010. Population uptake of antiretroviral treatment through primary care in rural South Africa. BMC Public Health 10. doi:10.1186/1471-2458-10-585
  3. Houlihan, C.F., Mutevedzi, P.C., Lessells, R.J., Cooke, G.S., Tanser, F.C., Newell, M.-L., 2010. The tuberculosis challenge in a rural South African HIV programme. BMC Infect. Dis. 10. doi:10.1186/1471-2334-10-23
  4. Ndirangu, J., Newell, M.-L., Tanser, F., Herbst, A.J., Bland, R., 2010. Decline in early life mortality in a high HIV prevalence rural area of South Africa: evidence of HIV prevention or treatment impact? AIDS 24, 593–602. doi:10.1097/QAD.0b013e328335cff5
  5. Pluess, B., Tanser, F.C., Lengeler, C., Sharp, B.L., 2010. Indoor residual spraying for preventing malaria, in: The Cochrane Collaboration (Ed.), Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester, UK.

 2009

  1. Bärnighausen, T., Tanser, F., Newell, M.-L., 2009. Lack of a decline in HIV incidence in a rural community with high HIV prevalence in South Africa, 2003-2007. AIDS Res. Hum. Retroviruses 25, 405–409. doi:10.1089/aid.2008.0211
  2. Bärnighausen, T., Tanser, F., 2009. Rethinking the role of the local community in HIV epidemic spread in sub-Saharan Africa: a proximate-determinants approach. HIV Ther 3, 435–445. doi:10.2217/hiv.09.33
  3. Herbst, A.J., Cooke, G.S., Bärnighausen, T., KanyKany, A., Tanser, F., Newell, M.-L., 2009. Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bull. World Health Organ. 87, 754–762. doi:10.1590/S0042-96862009001000011
  4. Ndirangu, J., Bärnighausen, T., Tanser, F., Tint, K., Newell, M.-L., 2009. Levels of childhood vaccination coverage and the impact of maternal HIV status on child vaccination status in rural KwaZulu-Natal, South Africa*. Trop. Med. Int. Health 14, 1383–1393. doi:10.1111/j.1365-3156.2009.02382.x
  5. Tanser, F., Bärnighausen, T., Cooke, G.S., Newell, M.-L., 2009. Localized spatial clustering of HIV infections in a widely disseminated rural South African epidemic. Int J Epidemiol 38, 1008–1016. doi:10.1093/ije/dyp148

 2008

  1. Bärnighausen, T., Tanser, F., Gqwede, Z., Mbizana, C., Herbst, K., Newell, M.-L., 2008. High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study. AIDS 22, 139–144. doi:10.1097/QAD.0b013e3282f2ef43
  2. Bärnighausen, T., Wallrauch, C., Welte, A., McWalter, T.A., Mbizana, N., Viljoen, J., Graham, N., Tanser, F., Puren, A., Newell, M.-L., 2008. HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing. PLoS ONE 3. doi:10.1371/journal.pone.0003640
  3. Bärnighausen, T., Welz, T., Hosegood, V., Bätzing-Feigenbaum, J., Tanser, F., Herbst, K., Hill, C., Newell, M.-L., 2008. Hiding in the shadows of the HIV epidemic: obesity and hypertension in a rural population with very high HIV prevalence in South Africa. J Hum Hypertens 22, 236–239. doi:10.1038/sj.jhh.1002308
  4. Tanser, F., Hosegood, V., Bärnighausen, T., Herbst, K., Nyirenda, M., Muhwava, W., Newell, C., Viljoen, J., Mutevedzi, T., Newell, M.-L., 2008. Cohort Profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol 37, 956–962. doi:10.1093/ije/dym211

 2007

  1. Rice, B.D., Bätzing-Feigenbaum, J., Hosegood, V., Tanser, F., Hill, C., Barnighausen, T., Herbst, K., Welz, T., Newell, M.-L., 2007. Population and antenatal-based HIV prevalence estimates in a high contracepting female population in rural South Africa. BMC Public Health 7. doi:10.1186/1471-2458-7-160

2006

  1. Tanser, F., 2006. Methodology for optimising location of new primary health care facilities in rural communities: a case study in KwaZulu-Natal, South Africa. J Epidemiol Community Health 60, 846–850. doi:10.1136/jech.2005.043265
  2. Tanser, F., 2006. Geographical Information Systems (GIS) Innovations For Primary Health Care in Developing Countries. Innovations: Technology, Governance, Globalization 1, 106–122. doi:10.1162/itgg.2006.1.2.106
  3. Tanser, F., Gijsbertsen, B., Herbst, K., 2006. Modelling and understanding primary health care accessibility and utilization in rural South Africa: an exploration using a geographical information system. Soc Sci Med 63, 691–705. doi:10.1016/j.socscimed.2006.01.015

2005

  1. Tanser, F., Sharp, B., 2005. Global climate change and malaria. Lancet Infect Dis 5, 256–258. doi:10.1016/S1473-3099(05)70091-8

2003

  1. Tanser, F.C., Sharp, B., le Sueur, D., 2003. Potential effect of climate change on malaria transmission in Africa. Lancet 362, 1792–1798. doi:10.1016/S0140-6736(03)14898-2

2002

  1. Tanser, F., Le Sueur, D., 2002. The application of geographical information systems to important public health problems in Africa. Int J Health Geogr 1, 4–4. doi:10.1186/1476-072X-1-4
  2. Tanser, F.C., 2002. The application of GIS technology to equitably distribute fieldworker workload in a large, rural South African health survey. Trop. Med. Int. Health 7, 80–90. doi:10.1046/j.1365-3156.2002.00825.x
  3. Tanser, F.C., Le Sueur, D., 2002. The application of geographical information systems to important public health problems in Africa. International Journal of Health Geographics 1, 4.

2001

  1. Tanser, F., Hosegood, V., Benzler, J., Solarsh, G., 2001. New approaches to spatially analyse primary health care usage patterns in rural South Africa. Trop. Med. Int. Health 6, 826–838.

2000

  1. Tanser, F., Lesueur, D., Solarsh, G., Wilkinson, D., 2000. HIV heterogeneity and proximity of homestead to roads in rural South Africa: an exploration using a geographical information system.
  2. Tanser, F., Palmer, A.R., 2000. Vegetation mapping of the Great Fish River basin, South Africa: Integrating spatial and multi-spectral remote sensing techniques. Applied Vegetation Science 3, 197–204. doi:10.2307/1478998

1999

  1. Tanser, F., Palmer, A.R., 1999. The application of a remotely-sensed diversity index to monitor degradation patterns in a semi-arid, heterogeneous, South African landscape. Journal of Arid Environments 43, 477–484. doi:10.1006/jare.1999.0568
  2. Tanser, F., Wilkinson, D., 1999. Spatial implications of the tuberculosis DOTS strategy in rural South Africa: a novel application of geographical information system and global positioning system technologies. Trop. Med. Int. Health 4, 634–638.
  3. Wilkinson, D., Tanser, F., 1999. GIS/GPS to document increased access to community-based treatment for tuberculosis in Africa. Geographic information system/global positioning system. Lancet 354, 394–395.

1998

  1. Craig, M., Snow, R., Tanser, F., Fraser, C., Binka, F., TourJ, Y., Lemardeley, P., Lengeler, C., deSavigny, D., Teuscher, T., Omumbo, J., Adjuik, M., Bagayoko, M., Fondjo, E., leSueur, D., 1998. Progress of the MARA/ARMA (mapping malaria risk in Africa) project. Parasitology International 47. doi:10.1016/S1383-5769(98)80157-8
  2. Snow, R.W., Gouws, E., Omumbo, J., Rapuoda, B., Craig, M.H., Tanser, F., le Sueur, D., Ouma, J., 1998. Models to predict the intensity of Plasmodium falciparum transmission: applications to the burden of disease in Kenya. Trans. R. Soc. Trop. Med. Hyg. 92, 601–606.

 

  1. Tanser, F., Bärnighausen, T., Grapsa, E., Zaidi, J., Newell, M.-L., 2013. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 339, 966–971. doi:10.1126/science.1228160
  2. Tanser, F., Bärnighausen, T., Hund, L., Garnett, G.P., McGrath, N., Newell, M.-L., 2011. Effect of concurrent sexual partnerships on rate of new HIV infections in a high-prevalence, rural South African population: a cohort study. Lancet 378, 247–255. doi:10.1016/S0140-6736(11)60779-4
  3. Tanser, F.C., Sharp, B., le Sueur, D., 2003. Potential effect of climate change on malaria transmission in Africa. Lancet 362, 1792–1798. doi:10.1016/S0140-6736(03)14898-2
  4. Tanser, F., de Oliveira, T., Maheu-Giroux, M., Bärnighausen, T., 2014. Concentrated HIV subepidemics in generalized epidemic settings. Curr Opin HIV AIDS 9, 115–125. doi:10.1097/COH.0000000000000034
  5. Tanser, F., Gijsbertsen, B., Herbst, K., 2006. Modelling and understanding primary health care accessibility and utilization in rural South Africa: an exploration using a geographical information system. Soc Sci Med 63, 691–705. doi:10.1016/j.socscimed.2006.01.015
  • Use of multi-level statistical models to understand causal pathways of HIV infection by quantifying community-, household- and individual-level determinants of HIV acquisition and transmission
  • Integration of spatial and genetic epidemiological approaches to inform targeted HIV intervention strategies
  • Measurement of spatial clustering of HIV infections and the impact of spatial structure on the dynamics, spread and persistence of the HIV epidemic
  • Use of remotely sensed satellite imagery and GIS to predict the distribution and intensity of transmission of urinary schistosomiasis
  • Assessing the impact of indoor residual spraying (IRS) on malaria outcomes
  • Application of geographical information systems to infectious diseases and health systems in Africa
  • Spatial modelling of malaria transmission and the impact of climate change on African and global malaria patterns
  • Geographic aspects of health care delivery

Prof Frank Tanser an infectious disease epidemiologist who has pioneered the use of geographical information systems (GIS) technology and spatial methods in the field of infectious disease epidemiology. His research has led to ground-breaking insights into the impact and evolution of the HIV epidemic in this era of enhanced HIV treatment and prevention interventions. He is currently Professor of Epidemiology in the College of Health Sciences University of KwaZulu Natal and Research Director of the Epidemiology and Population Studies Programme at the Africa Centre for Population Health. He further holds an honorary professorship at University College London in the Institute of Epidemiology & Health Care.  He was a founder member of the Africa Centre for Population Health Studies (started in 1998) and was responsible for setting up the GIS unit at the Africa Centre for Population Health which has since achieved international recognition for the novel application of spatial methods to infectious diseases and health systems research. 

Prof Tanser has published extensively in high-ranking international journals (including Science, PLoS Medicine, Lancet Infectious Diseases and 4 papers in The Lancet) and his work has been cited over 3,480 times (H-Index 33, Google Scholar). In 2013, he led some research (published in Science) that provided the first conclusive evidence that population-level reductions in the transmission of HIV could be achieved in public-sector ART programs in rural sub-Saharan African settings. The study had wide-reaching and rapid policy impacts as the first results of several population-based cluster-randomized trials testing this hypothesis were only expected in late 2016.  He has been the recipient of numerous scientific grants and have raised over 450 million Rand (50 million US dollars) in external research funding to date. Most recently he was awarded an MRC flagship grant (which aims to use novel methods to understand patterns of HIV transmission and drug resistance in a typical rural African population) and R01 grant from the US NICHD (which aims to identify and quantify causal pathways to population health impact of HIV antiretroviral treatment).  He has served as a consultant and advisor to several high profile organisations including the Mailman School of Public Health, USAID, the Futures Group International and UNAIDS. He currently serves on the editorial board of the Lancet HIV, is an academic editor of PLoS One and a member of the International Scientific and Technical Advisory Committee of the UNAIDS 90-90-90 Target.